awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38669276-C2D3B9C9-6FC6-4775-925F-0B6653BD3A9E
Q38669276-C2D3B9C9-6FC6-4775-925F-0B6653BD3A9E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38669276-C2D3B9C9-6FC6-4775-925F-0B6653BD3A9E
Anti-angiogenesis in Personalized Therapy of Lung Cancer.
P2860
Q38669276-C2D3B9C9-6FC6-4775-925F-0B6653BD3A9E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38669276-C2D3B9C9-6FC6-4775-925F-0B6653BD3A9E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
500e4eb77dba9d430c186859bbe1156340c8804d
P2860
NCIC CTG IND.190 phase I trial of dalotuzumab (MK-0646) in combination with cisplatin and etoposide in extensive-stage small-cell lung cancer.